Selective Use of Pulmonary Vasodilators in Patients with Fontan Physiology.

Thomas GlennNicole DusterJerry DwekJose Silva-SepulvedaHowaida G El-Said

Published in: Journal of interventional cardiology (2022)

These data demonstrate indeterminate results for the selective use of pulmonary vasodilators but highlight the need for large prospective randomized control trials of pulmonary vasodilator therapies to fully assess the benefit of such therapies in Fontan-associated liver disease.

Keyphrases

pulmonary hypertension
electronic health record
clinical trial
phase iii
phase ii
deep learning
data analysis